Rare Case of Fatal Yellow Fever Vaccine-associated Viscerotropic Disease
- 1 June 2005
- journal article
- case report
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 98 (6) , 653-656
- https://doi.org/10.1097/01.smj.0000157537.11806.dc
Abstract
This report describes a case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) that occurred after vaccination in a 22-year-old female. Our patient presented with a clinical syndrome of fever, headache, nausea, and vomiting, which quickly progressed to multiorgan failure and ultimately death on hospital day 4. YEL-AVD is an extremely rare condition reported only a few times in the literature. The yellow fever vaccine is a known stimulus of systemic inflammation in the body. A mild subclinical viremia develops, which results in a persistent and robust T-helper-cell-dependent antibody response with long-lasting immune protection. The very rare patient may have an aberrant response to the 17D vaccine strain, causing the multiple organ system failure seen in YEL-AVD. Predisposing host factors that contribute to YEL-AVD are not yet known. Treatment for YEL-AVD is supportive. To the authors' knowledge, this patient was the first to have YEL-AVD as a result of standard US military vaccination protocols.Keywords
This publication has 16 references indexed in Scilit:
- Yellow fever: readily prevented but difficult to treatCMAJ : Canadian Medical Association Journal, 2004
- Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeysVirology, 2003
- Mind, Body, and Medicine: An Integrative TextPublished by American Medical Association (AMA) ,2002
- Yellow fever vaccination as a model to study the response to stimulation of the inflammation systemVascular Pharmacology, 2002
- Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four casesThe Lancet, 2001
- Travel-Related VaccinesInfectious Disease Clinics of North America, 2001
- Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.The American Journal of Tropical Medicine and Hygiene, 1999
- Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infectionJournal of Medical Virology, 1998
- In Vivo Synthesis of Tumor Necrosis Factor‐α in Healthy Humans after Live Yellow Fever VaccinationThe Journal of Infectious Diseases, 1998
- Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old childPublished by American Medical Association (AMA) ,1966